184 related articles for article (PubMed ID: 38069221)
1. Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.
Toth D; Dudas B; Miteva MA; Balog E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069221
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain.
Salman ED; Kadlubar SA; Falany CN
Drug Metab Dispos; 2009 Apr; 37(4):706-9. PubMed ID: 19171676
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies.
Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME
Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143
[TBL] [Abstract][Full Text] [Related]
4. Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulations.
Dudas B; Toth D; Perahia D; Nicot AB; Balog E; Miteva MA
Sci Rep; 2021 Jun; 11(1):13129. PubMed ID: 34162941
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human iodothyronine sulfotransferases.
Kester MH; Kaptein E; Roest TJ; van Dijk CH; Tibboel D; Meinl W; Glatt H; Coughtrie MW; Visser TJ
J Clin Endocrinol Metab; 1999 Apr; 84(4):1357-64. PubMed ID: 10199779
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
Dajani R; Hood AM; Coughtrie MW
Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.
Cook I; Wang T; Leyh TS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5317-E5324. PubMed ID: 28630292
[TBL] [Abstract][Full Text] [Related]
8. Spectrofluorometric assay for monoamine-preferring phenol sulfotransferase (SULT1A3).
Lu LY; Hsu YC; Yang YS
Anal Biochem; 2010 Sep; 404(2):241-3. PubMed ID: 20566371
[TBL] [Abstract][Full Text] [Related]
9. In silico mechanistic profiling to probe small molecule binding to sulfotransferases.
Martiny VY; Carbonell P; Lagorce D; Villoutreix BO; Moroy G; Miteva MA
PLoS One; 2013; 8(9):e73587. PubMed ID: 24039991
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells.
Mitra P; Audus KL
Biochem Pharmacol; 2009 Dec; 78(12):1475-82. PubMed ID: 19646966
[TBL] [Abstract][Full Text] [Related]
11. Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.
Hui Y; Liu MC
Eur J Pharmacol; 2015 Aug; 761():125-9. PubMed ID: 25941087
[TBL] [Abstract][Full Text] [Related]
12. Thermostable (SULT1A1) and thermolabile (SULT1A3) phenol sulfotransferases in human osteosarcoma and osteoblast cells.
Dubin RL; Hall CM; Pileri CL; Kudlacek PE; Li XY; Yee JA; Johnson ML; Anderson RJ
Bone; 2001 Jun; 28(6):617-24. PubMed ID: 11425650
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
Nishimuta H; Ohtani H; Tsujimoto M; Ogura K; Hiratsuka A; Sawada Y
Biopharm Drug Dispos; 2007 Dec; 28(9):491-500. PubMed ID: 17876860
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the Brain-Selective Sulfotransferase SULT4A1 with Other Cytosolic Sulfotransferases: Effects on Protein Expression and Function.
Idris M; Mitchell DJ; Gordon R; Sidharthan NP; Butcher NJ; Minchin RF
Drug Metab Dispos; 2020 May; 48(5):337-344. PubMed ID: 32152050
[TBL] [Abstract][Full Text] [Related]
15. Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1.
Wang T; Cook I; Leyh TS
Biochemistry; 2016 Jul; 55(29):4036-46. PubMed ID: 27356022
[TBL] [Abstract][Full Text] [Related]
16. Design and Interpretation of Human Sulfotransferase 1A1 Assays.
Wang T; Cook I; Leyh TS
Drug Metab Dispos; 2016 Apr; 44(4):481-4. PubMed ID: 26658224
[TBL] [Abstract][Full Text] [Related]
17. Human thyroid phenol sulfotransferase enzymes 1A1 and 1A3: activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens.
Ebmeier CC; Anderson RJ
J Clin Endocrinol Metab; 2004 Nov; 89(11):5597-605. PubMed ID: 15531517
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific therapeutic control of sulfonation in humans.
Cook I; Wang T; Leyh TS
Biochem Pharmacol; 2019 Jan; 159():25-31. PubMed ID: 30423313
[TBL] [Abstract][Full Text] [Related]
19. Interactions of cytosolic sulfotransferases with xenobiotics.
James MO; Ambadapadi S
Drug Metab Rev; 2013 Nov; 45(4):401-14. PubMed ID: 24188364
[TBL] [Abstract][Full Text] [Related]
20. Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.
Tibbs ZE; Rohn-Glowacki KJ; Crittenden F; Guidry AL; Falany CN
Drug Metab Pharmacokinet; 2015 Feb; 30(1):3-20. PubMed ID: 25760527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
